ATC Group: G03X Other sex hormones and modulators of the genital system

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G03X in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G03 Sex hormones and modulators of the genital system
3 G03X Other sex hormones and modulators of the genital system

Group G03X contents

Code Title
G03XA Antigonadotropins and similar agents
G03XB Antiprogestogens
G03XC Selective estrogen receptor modulators
G03XX Other sex hormones and modulators of the genital system

Active ingredients in G03X

Active Ingredient Description
Bazedoxifene
Danazol

Danazol is a synthetic steroid derived from ethisterone an is indicated for the treatment of endometriosis and benign fibrocystic breast disease.

Mifepristone

Mifepristone is a synthetic steroid with an antiprogestational action as a result of competition with progesterone at the progesterone receptors.

Ospemifene

Ospemifene and its major metabolite have an oestrogen like effect in the vagina increasing the cellular maturation and mucification of the vaginal epithelium. Ospemifene’s biological actions are mediated through the binding of ospemifene and its major metabolite to oestrogen receptors leading to activation of some oestrogenic pathways (agonism) and blockade of other (antagonism).

Prasterone

Prasterone, i.e. dehydroepiandrosterone (DHEA), biochemically and biologically identical to the endogenous human DHEA, is a precursor steroid which is inactive by itself and it is converted into oestrogens and androgens. Intrarosa is thus different from the oestrogens preparations since it delivers also androgen metabolites.

Raloxifene

As a selective oestrogen receptor modulator (SERM), raloxifene has selective agonist or antagonist activities on tissues responsive to oestrogen. It acts as an agonist on bone and partially on cholesterol metabolism (decrease in total and LDL-cholesterol), but not in the hypothalamus or in the uterine or breast tissues.

Ulipristal

Ulipristal is an orally-active synthetic selective progesterone receptor modulator which acts via high-affinity binding to the human progesterone receptor. When used for emergency contraception the mechanism of action is inhibition or delay of ovulation via suppression of the luteinising hormone (LH) surge. Pharmacodynamic data show that even when taken immediately before ovulation is scheduled to occur (when LH has already started to rise), ulipristal acetate is able to postpone follicular rupture for at least 5 days.

Related product monographs

Title Information Source Document Type  
ANARGIL Capsule, hard Υπουργείο Υγείας (CY) MPI, EU: SmPC
CONBRIZA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
ESMYA Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
EVISTA Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
EVISTA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
MEDABON CO Tablet, Vaginal tablet Health Products Regulatory Authority (ZA) MPI, Generic
MIFEGYNE Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
OPTRUMA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
ORILISSA Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
SENSHIO Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC